A Plus Biotechnology Co., Ltd. (TPE:6918)
70.70
-1.90 (-2.62%)
Nov 20, 2026, 1:30 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.41 billion as of November 20, 2026. It is the 26,769th most valuable company in the world and the 1,408th biggest in Taiwan. Its market cap has decreased by 19.45% in one year.
Market Cap
2.41B
Enterprise Value
2.09B
Revenue
919.38M
Global Rank
Country Rank
#1,408 Taiwan
PE Ratio
12.30
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.41B, an increase of 58.11%. That is a compound annual growth rate of 12.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.41B | -18.51% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 78.73% |
| Dec 29, 2023 | 1.37B | -10.26% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.21B |
| Apex Biotechnology | 2.80B |
| Bonraybio | 2.67B |
| Wellell | 2.43B |
| Applied BioCode | 2.14B |
| Dynamic Medical Technologies | 1.98B |
| OK Biotech | 1.91B |
| Medimaging Integrated Solution | 1.58B |